Ligand Pharmaceuticals (LGND) Jumps: Stock Rises 5.5%

Zacks

Ligand Pharmaceuticals Inc. (LGND) was a big mover last session, as the company saw its shares rise by over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has now gained roughly 27% since Nov 7.

This healthcare company has seen a mixed track record when it comes to estimate revision with an upward and downward revision apiece in the past one month. The Zacks Consensus Estimate hasn’t been in a trend either. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Ligand Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Some better-ranked stocks in the same industry include Jazz Pharmaceuticals Public Limited Company (JAZZ), Lannett Company, Inc. (LCI) and Questcor Pharmaceuticals, Inc. (QCOR). All these stocks hold a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



LIGAND PHARMACEUTICALS (LGND): Free Stock Analysis Report

JAZZ PHARMACEUTICALS PLC IRELAND (JAZZ): Free Stock Analysis Report

LANNETT CO INC (LCI): Free Stock Analysis Report

QUESTCOR PHARMACEUTICALS INC (QCOR): Free Stock Analysis Report


Zacks Investment Research

View Comments (0)